JP2019536457A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019536457A5 JP2019536457A5 JP2019529204A JP2019529204A JP2019536457A5 JP 2019536457 A5 JP2019536457 A5 JP 2019536457A5 JP 2019529204 A JP2019529204 A JP 2019529204A JP 2019529204 A JP2019529204 A JP 2019529204A JP 2019536457 A5 JP2019536457 A5 JP 2019536457A5
- Authority
- JP
- Japan
- Prior art keywords
- human
- recombinant
- cells
- mouse
- immunodeficient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022166015A JP2023015064A (ja) | 2016-11-30 | 2022-10-17 | 改善されたヒト自然免疫細胞の発生を有するヒト化マウスモデル |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662428131P | 2016-11-30 | 2016-11-30 | |
| US62/428,131 | 2016-11-30 | ||
| US201762565783P | 2017-09-29 | 2017-09-29 | |
| US62/565,783 | 2017-09-29 | ||
| PCT/US2017/063948 WO2018102546A1 (en) | 2016-11-30 | 2017-11-30 | Humanized mouse model with improved human innate immune cell development |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022166015A Division JP2023015064A (ja) | 2016-11-30 | 2022-10-17 | 改善されたヒト自然免疫細胞の発生を有するヒト化マウスモデル |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019536457A JP2019536457A (ja) | 2019-12-19 |
| JP2019536457A5 true JP2019536457A5 (cg-RX-API-DMAC7.html) | 2021-01-21 |
| JP7458185B2 JP7458185B2 (ja) | 2024-03-29 |
Family
ID=60935945
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019529204A Active JP7458185B2 (ja) | 2016-11-30 | 2017-11-30 | 改善されたヒト自然免疫細胞の発生を有するヒト化マウスモデル |
| JP2022166015A Pending JP2023015064A (ja) | 2016-11-30 | 2022-10-17 | 改善されたヒト自然免疫細胞の発生を有するヒト化マウスモデル |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022166015A Pending JP2023015064A (ja) | 2016-11-30 | 2022-10-17 | 改善されたヒト自然免疫細胞の発生を有するヒト化マウスモデル |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US20190320633A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3547831B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7458185B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN110740641A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018102546A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018102546A1 (en) * | 2016-11-30 | 2018-06-07 | The Jackson Laboratory | Humanized mouse model with improved human innate immune cell development |
| US11778994B2 (en) | 2017-05-12 | 2023-10-10 | The Jackson Laboratory | NSG mice lacking MHC class I and class II |
| US11712026B2 (en) | 2017-10-18 | 2023-08-01 | The Jackson Laboratory | Murine-MHC-deficient HLA-transgenic nod-mouse models for T1D therapy development |
| US20210355501A1 (en) * | 2018-09-24 | 2021-11-18 | Albert Einstein College Of Medicine | Interleukin-8 for maintenance of human acute myeloid leukemia and myelodysplastic syndrome and uses thereof |
| US20220192166A1 (en) * | 2019-03-28 | 2022-06-23 | Central Institute For Experimental Animals | Immunodeficient rodent |
| US20220312749A1 (en) * | 2019-08-09 | 2022-10-06 | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. | Genetically modified non-human animal with human or chimeric il2ra |
| CN111705082A (zh) * | 2020-04-14 | 2020-09-25 | 澎立生物医药技术(上海)有限公司 | 具有髓系免疫细胞的人源化免疫系小鼠的构建方法 |
| US20230270085A1 (en) * | 2020-07-08 | 2023-08-31 | The Jackson Laboratory | Transgenic mouse model expressing human hla-a201 restriction gene |
| AU2021347320A1 (en) | 2020-09-24 | 2023-05-11 | The Jackson Laboratory | Humanized mouse models for assessing immune cell therapy |
| CN114853871B (zh) * | 2021-04-20 | 2024-04-05 | 百奥赛图(北京)医药科技股份有限公司 | Csf1和/或csf1r基因人源化的非人动物及其构建方法和应用 |
| CA3244028A1 (en) * | 2021-12-22 | 2023-06-29 | The Jackson Laboratory | HUMANIZED WALL MODELS |
| JP2025525451A (ja) | 2022-06-30 | 2025-08-05 | ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ | Cd25特異的抗体およびその使用 |
| CN117070522A (zh) * | 2022-08-15 | 2023-11-17 | 江苏集萃药康生物科技股份有限公司 | 一种细胞因子人源化的非人动物的制备方法及其应用 |
| AU2023338373A1 (en) * | 2022-09-08 | 2025-04-03 | The Jackson Laboratory | Humanized immunodeficient mouse models |
| US20260144239A1 (en) * | 2022-10-25 | 2026-05-28 | Lapix Therapeutics, Inc. | Immune Cell-Engrafted Non-Human Animals and Non-Human Animal Models |
| WO2025041060A1 (en) * | 2023-08-21 | 2025-02-27 | VeraVerse Co., Ltd. | Patient-derived xenograft model of cancer, preparation method thereof and an apparatus and a method for analyzing drug responsiveness using the same |
| WO2026001958A1 (zh) * | 2024-06-24 | 2026-01-02 | 黄菁 | Aav载体、aav载体的组合、构建aml pdx和mm pdx非人动物的方法及构建免疫系统人源化非人动物的方法 |
| CN121891523A (zh) * | 2026-03-24 | 2026-04-21 | 广东莱迪生物医药研究院有限公司 | 一种模拟肿瘤免疫微环境的双人源化小鼠模型及其应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1209968A1 (en) | 1999-08-31 | 2002-06-05 | Genencor International, Inc. | Transgenic mammal capable of facilitating production of donor-specific functional immunity |
| EP1802193B1 (en) * | 2004-10-19 | 2014-04-30 | Regeneron Pharmaceuticals, Inc. | Method for generating a mouse homozygous for a genetic modification |
| PT4233537T (pt) * | 2011-02-15 | 2025-09-08 | Regeneron Pharma | Ratinhos humanizados para m-csf e utilizações dos mesmos |
| KR102241962B1 (ko) * | 2012-09-07 | 2021-04-20 | 예일 유니버시티 | 유전적으로 변형된 비-인간 동물 및 이것들의 사용 방법 |
| DK4389764T3 (da) * | 2012-11-05 | 2026-04-13 | Regeneron Pharma | Genetisk modificerede gnavere og fremgangsmåder til anvendelse heraf |
| JP6492095B2 (ja) | 2013-10-15 | 2019-03-27 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. | ヒト化il−15動物 |
| US20150282460A1 (en) | 2014-04-04 | 2015-10-08 | Crown Bioscience Inc. (Taicang) | Animal model with human immune system |
| EP3482629B1 (en) * | 2014-05-19 | 2020-11-25 | Regeneron Pharmaceuticals, Inc. | Genetically modified non-human animals expressing human epo |
| ES2950399T3 (es) | 2015-04-13 | 2023-10-09 | Regeneron Pharma | Ratones humanizados Sirpa-IL15 insertados y métodos de uso de los mismos |
| JP6654001B2 (ja) * | 2015-05-27 | 2020-02-26 | 公益財団法人実験動物中央研究所 | ヒトil−15分泌免疫不全マウス |
| TWI810145B (zh) * | 2015-06-23 | 2023-08-01 | 杰克森實驗室 | 具有病患衍生之異種移植物之非hla配對的人源化nsg小鼠模式 |
| AU2016343860A1 (en) | 2015-10-30 | 2018-05-10 | The Jackson Laboratory | Compositions and methods relating to tumor analysis |
| AU2017348348A1 (en) | 2016-10-27 | 2019-05-02 | The Jackson Laboratory | Genetically modified mouse model for human hepatocyte xenotransplantation |
| WO2018102546A1 (en) * | 2016-11-30 | 2018-06-07 | The Jackson Laboratory | Humanized mouse model with improved human innate immune cell development |
| AU2018291497A1 (en) * | 2017-06-30 | 2020-01-16 | Xencor, Inc. | Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15Ra and antigen binding domains |
| IL272475B2 (en) | 2017-08-09 | 2025-05-01 | Jackson Lab | Immunodeficient mice expressing interleukin 15 |
| TWI838389B (zh) | 2018-07-19 | 2024-04-11 | 美商再生元醫藥公司 | 雙特異性抗-BCMAx抗-CD3抗體及其用途 |
| AU2019374055B2 (en) | 2018-10-30 | 2026-06-11 | Regeneron Pharmaceuticals, Inc. | Methods for allogeneic hematopoietic stem cell transplantation |
-
2017
- 2017-11-30 WO PCT/US2017/063948 patent/WO2018102546A1/en not_active Ceased
- 2017-11-30 JP JP2019529204A patent/JP7458185B2/ja active Active
- 2017-11-30 CN CN201780083557.8A patent/CN110740641A/zh active Pending
- 2017-11-30 US US16/465,006 patent/US20190320633A1/en not_active Abandoned
- 2017-11-30 EP EP17825653.3A patent/EP3547831B1/en active Active
-
2022
- 2022-10-17 JP JP2022166015A patent/JP2023015064A/ja active Pending
-
2024
- 2024-06-28 US US18/758,838 patent/US12409237B1/en active Active
-
2025
- 2025-08-15 US US19/301,265 patent/US20260033467A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mian et al. | Advances in human immune system mouse models for studying human hematopoiesis and cancer immunotherapy | |
| Hanazawa et al. | Generation of human immunosuppressive myeloid cell populations in human interleukin-6 transgenic NOG mice | |
| McCaughtry et al. | Conditional deletion of cytokine receptor chains reveals that IL-7 and IL-15 specify CD8 cytotoxic lineage fate in the thymus | |
| JP2022105531A (ja) | 遺伝学的に修飾された非ヒト動物およびその使用法 | |
| EP3475413B1 (en) | Genetically modified t lymphocytes | |
| Delconte et al. | NK cell priming from endogenous homeostatic signals is modulated by CIS | |
| US20190167720A1 (en) | Gene editing for immunological destruction of neoplasia | |
| JP2012531896A5 (cg-RX-API-DMAC7.html) | ||
| Chou et al. | Immunomodulatory effects of Saccharomyces cerevisiae fermentation product supplementation on immune gene expression and lymphocyte distribution in immune organs in broilers | |
| US20220226379A1 (en) | Dnmt3a knock-out stat5 activated genetically engineered t-cells | |
| Stacey et al. | IL-10 restricts activation-induced death of NK cells during acute murine cytomegalovirus infection | |
| JP2020520367A5 (cg-RX-API-DMAC7.html) | ||
| Volk et al. | Multidimensional analysis integrating human T-cell signatures in lymphatic tissues with sex of humanized mice for prediction of responses after dendritic cell immunization | |
| US11725187B2 (en) | Selection of human hematopoetic stem cells using EPCR | |
| Li et al. | Thymic selection pathway regulates the effector function of CD4 T cells | |
| WO2017049002A1 (en) | A humanized mouse model of de novo human acute myeloid leukemia with a matching human immune system | |
| Prlic et al. | Dissociating markers of senescence and protective ability in memory T cells | |
| Ishikawa | Modeling normal and malignant human hematopoiesis in vivo through newborn NSG xenotransplantation | |
| Powell et al. | SCID pigs: An emerging large animal NK model | |
| CN111372449B (zh) | 免疫缺陷小鼠 | |
| Panjwani et al. | Single-cell profiling aligns CD56bright and cytomegalovirus-induced adaptive natural killer cells to a naïve-memory relationship | |
| Mendoza-Valderrey et al. | Next generation immuno-oncology strategies: unleashing NK cells activity | |
| Chun et al. | Engraftment of adult hematopoietic stem and progenitor cells in a novel model of humanized mice | |
| Zheng et al. | FLT3L combined with GM-CSF induced dendritic cells drive broad tumor-specific CD8+ T cell responses and remodel the tumor microenvironment to enhance anti-tumor efficacy | |
| Pisano et al. | Laboratory mice–A driving force in immunopathology and immunotherapy studies of human multiple myeloma |